Answers are grounded in this paper and cite their sources.
With a constellation of stem cell sources available, researchers hope to utilize their potential for cellular repair as a therapeutic target for disease. However, many lab-to-clinic translational considerations must be given in determining their efficacy, variables such as the host response, effects on native tissue, and potential for generating tumors. This review will discuss the current knowledge of stem cell research in neurological disease, mainly stroke, with a focus on the benefits, limitations, and clinical potential.
No takes yet. Share an insight, caveat, or question.
Dailey et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: